Health care utilization and economic burden of dermatologic adverse drug reactions (ADRs) in patients with colorectal cancer treated with an epidermal growth factor receptor inhibitor (EGFRI). Updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results